We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.83%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$851B
AUM Growth
+$80.9B
Cap. Flow
+$19.9B
Cap. Flow %
2.34%
Top 10 Hldgs %
25.93%
Holding
4,889
New
83
Increased
3,362
Reduced
611
Closed
132

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.18B
2
AAPL icon
Apple
AAPL
+$1.11B
3
AVGO icon
Broadcom
AVGO
+$562M
4
AMZN icon
Amazon
AMZN
+$553M
5
PANW icon
Palo Alto Networks
PANW
+$485M

Sector Composition

Rank Sector Weight
1 Technology 28.24%
2 Healthcare 13.33%
3 Financials 12.09%
4 Consumer Discretionary 10.85%
5 Industrials 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTRU
3901
DELISTED
Vitru Limited Common Shares
VTRU
$272K ﹤0.01%
16,975
+720
+4% +$11.5K
INAB icon
3902
IN8bio
INAB
$9.88M
$272K ﹤0.01%
5,885
+3,957
+205% +$247K
NAII icon
3903
Natural Alternatives International
NAII
$14.4M
$272K ﹤0.01%
36,621
DNTH icon
3904
Dianthus Therapeutics
DNTH
$5.84B
$271K ﹤0.01%
22,356
UCAR
3905
U Power Ltd
UCAR
$26M
$271K ﹤0.01%
+38
New +$244K
FINV
3906
FinVolution Group
FINV
$1.15B
$271K ﹤0.01%
58,830
+4,339
+8% +$17.9K
SYRE icon
3907
Spyre Therapeutics
SYRE
$8.54B
$271K ﹤0.01%
24,018
SIEN
3908
DELISTED
Sientra, Inc.
SIEN
$270K ﹤0.01%
92,254
+36,601
+66% +$65.2K
AUTL
3909
Autolus Therapeutics
AUTL
$397M
$269K ﹤0.01%
112,945
+59,209
+110% +$140K
TISI icon
3910
Team
TISI
$79.5M
$269K ﹤0.01%
32,360
EIGR
3911
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$267K ﹤0.01%
12,647
-13,611
-52% -$419K
USAU icon
3912
US Gold Corp
USAU
$214M
$267K ﹤0.01%
59,947
+6,336
+12% +$27.9K
SOHU
3913
Sohu.com
SOHU
$362M
$266K ﹤0.01%
24,154
FAAS
3914
DELISTED
DigiAsia
FAAS
$266K ﹤0.01%
24,501
+171
+0.7% +$1.83K
HGAS
3915
DELISTED
Global Gas Corporation Class A Common Stock
HGAS
$265K ﹤0.01%
26,599
GTIM icon
3916
Good Times Restaurants
GTIM
$14.6M
$262K ﹤0.01%
76,994
MAQC
3917
DELISTED
Maquia Capital Acquisition Corporation Class A Common Stock
MAQC
$261K ﹤0.01%
23,638
KVSA
3918
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
$260K ﹤0.01%
24,911
ARKR icon
3919
Ark Restaurants
ARKR
$259K ﹤0.01%
14,017
KALA icon
3920
KALA BIO
KALA
$14.1M
$259K ﹤0.01%
+355
New +$276K
CRESY
3921
Cresud
CRESY
$795M
$259K ﹤0.01%
34,112
+2,299
+7% +$15K
ATAI icon
3922
AtaiBeckley Inc
ATAI
$2.66B
$259K ﹤0.01%
150,536
+33,310
+28% +$61.3K
MOVE icon
3923
Corvex Inc
MOVE
$299M
$258K ﹤0.01%
2,147
+526
+32% +$63.3K
PDYN icon
3924
Palladyne AI
PDYN
$247M
$258K ﹤0.01%
129,761
-154,521
-54% -$369K
CRBP icon
3925
Corbus Pharmaceuticals
CRBP
$166M
$258K ﹤0.01%
32,865

Similar funds

Geode Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Geode Capital Management held 4,889 positions worth $851B, up 11% from $770B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 4.4%. Geode Capital Management opened 83 new positions and exited 132, leaving the 4,889-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q2 2023 buy was Coupang: 4,567,454 shares worth $79.5M.
  • Geode Capital Management added most to Microsoft in Q2 2023, an estimated $1.18B increase.
  • Geode Capital Management's biggest Q2 2023 reduction was Procter & Gamble, cutting an estimated $246M.
  • Geode Capital Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $111M.
  • Geode Capital Management's ten largest holdings make up 26% of its $851B portfolio in Q2 2023.
  • Geode Capital Management opened 83 new positions and closed 132 in Q2 2023.
  • Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $851B.

Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.